3-MPPI
3-MPPI is a GPCR ligand with high selectivity for α1-adrenergic receptor, with a Ki value of 0.21 nM for α1-adrenergic receptor and 50 nM for 5-HT1A receptor. 3-MPPI modulates the α1-adrenergic receptor signaling cascade. 3-MPPI is applicable to research related to hypertension, stress-induced anxiety-like behavioral responses, and levodopa-induced dyskinesia.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 133399-65-2
- Fòrmula: C23H25N5O3
- Peso molecular:419.49
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas Adrenergic Receptor
More
Actividad biológica
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Caco-2 | Inhibition |
9.14 %
Compound: 3-MPPI
|
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging
|
10.21203/rs.3.rs-23951/v1 |
3-MPPI (compound RN5) derivatives exhibit exceptional α1-adrenoceptor (α1-AR) affinity (Ki = 2.71 nM) and selectivity over 5-HT1A receptors (5-HT1A/α1 ratio > 3500)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 133399-65-2
-
Peso molecular 419.49
-
Fòrmula C23H25N5O3
-
SMILES
O=C1NC=2C=3C=CC=CC3NC2C(=O)N1CCN4CCN(C=5C=CC=CC5OC)CC4
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- 3-MPPI
- 133399-65-2
- Adrenergic Receptor
- G protein-coupled Bile Acid Receptor 1
- benign prostatic hyperplasia
- stress-induced anxiety-like behavioral responses
- l-dopa-induced dyskinesia
- GPCR ligand
- α1-adrenoceptor
- lower urinary tract symptoms
- hypertension
- myocardial hypertrophy
- 5-HT1A receptor
- human α1?-AR
- Inhibitor
- inhibitor
- inhibit